Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
POINT Biopharma Global (PNT)
NASDAQ:PNT
POINT Biopharma Global (PNT) Stock Price & Analysis
39 Followers
PNT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.31 - $10.98
Previous Close$6.78
Volume562.76K
Average Volume (3M)566.52K
Market Cap
$739.78M
Enterprise Value$448.26M
Total Cash (Recent Filing)$291.52M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)8.4
Beta0.74
Next Earnings
May 12, 2023EPS Estimate
-$0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.81
Shares Outstanding105,644,741
10 Day Avg. Volume696,582
30 Day Avg. Volume566,518
Standard Deviation0.16
R-Squared0.00243
Alpha-0.00905
Financial Highlights & Ratios
Price to Book (P/B)2.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-11.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.67
Forecast
1Y Price Target
$14.33Price Target Upside111.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
POINT Biopharma Global News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PNT FAQ
What was POINT Biopharma Global’s price range in the past 12 months?
POINT Biopharma Global lowest stock price was $5.31 and its highest was $10.98 in the past 12 months.
What is POINT Biopharma Global’s market cap?
Currently, no data Available
When is POINT Biopharma Global’s upcoming earnings report date?
POINT Biopharma Global’s upcoming earnings report date is May 12, 2023 which is in 44 days.
How were POINT Biopharma Global’s earnings last quarter?
POINT Biopharma Global released its earnings results on Mar 27, 2023. The company reported $1.53 earnings per share for the quarter, beating the consensus estimate of -$0.262 by $1.792.
Is POINT Biopharma Global overvalued?
According to Wall Street analysts POINT Biopharma Global’s price is currently Undervalued.
Does POINT Biopharma Global pay dividends?
POINT Biopharma Global does not currently pay dividends.
What is POINT Biopharma Global’s EPS estimate?
POINT Biopharma Global’s EPS estimate is -$0.32.
How many shares outstanding does POINT Biopharma Global have?
POINT Biopharma Global has 105,682,680 shares outstanding.
What happened to POINT Biopharma Global’s price movement after its last earnings report?
POINT Biopharma Global reported an EPS of $1.53 in its last earnings report, beating expectations of -$0.262. Following the earnings report the stock price went up 2.79%.
Which hedge fund is a major shareholder of POINT Biopharma Global?
Among the largest hedge funds holding POINT Biopharma Global’s share is Baker Bros Advisors LP. It holds POINT Biopharma Global’s shares valued at 9M.
---
POINT Biopharma Global Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.33 (111.36% Upside)
$14.33 (111.36% Upside)
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $125.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.37%
12-Months-Change
Fundamentals
Return on Equity
26.49%
Trailing 12-Months
Asset Growth
120.16%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
POINT Biopharma Global
Therapeutics Acquisition Corp is a blank check company.
---
Top 5 ETFs holding PNT
iShares Russell 3000 ETF
BMO MSCI Innovation Index ETF
Up to five ETFs with an Outperform Smart Score that hold PNT. The ETFs are listed according to market value of PNT within the ETF
---
---